1.46
-0.02(-1.35%)
Currency In USD
| Previous Close | 1.48 |
| Open | 1.49 |
| Day High | 1.54 |
| Day Low | 1.45 |
| 52-Week High | 34 |
| 52-Week Low | 1.41 |
| Volume | 125,851 |
| Average Volume | 798,174 |
| Market Cap | 1.04M |
| PE | -0.02 |
| EPS | -62.4 |
| Moving Average 50 Days | 2.55 |
| Moving Average 200 Days | 4.06 |
| Change | -0.02 |
If you invested $1000 in Psyence Biomedical Ltd. (PBM) since IPO date, it would be worth $0.39 as of December 19, 2025 at a share price of $1.46. Whereas If you bought $1000 worth of Psyence Biomedical Ltd. (PBM) shares 1 year ago, it would be worth $0.39 as of December 19, 2025 at a share price of $1.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacific Bay Announces Sale of Sphinx Property, Critical Minerals Impact at Haskins-Reed and Financing Update
Newsfile
Nov 18, 2025 9:00 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - David H. Brett, Chairman of Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") is pleased to announce several corporate initiatives including the sale of its 100%
Pacific Bay Announces Non-Brokered Financing
Newsfile
Sep 25, 2025 8:33 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - David H. Brett, Chairman of Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") reports that the Company is pleased to announce a non-brokered private placement o
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Newsfile
Jun 18, 2025 12:30 PM GMT
Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS)Denver, Colorado--(Newsfile Corp. - June 18, 2025) - Psyence Biomedical